1. Home
  2. HHS vs BRNS Comparison

HHS vs BRNS Comparison

Compare HHS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HHS
  • BRNS
  • Stock Information
  • Founded
  • HHS 1923
  • BRNS 2016
  • Country
  • HHS United States
  • BRNS United Kingdom
  • Employees
  • HHS N/A
  • BRNS N/A
  • Industry
  • HHS Advertising
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HHS Consumer Discretionary
  • BRNS Health Care
  • Exchange
  • HHS Nasdaq
  • BRNS Nasdaq
  • Market Cap
  • HHS 52.3M
  • BRNS 41.0M
  • IPO Year
  • HHS N/A
  • BRNS 2021
  • Fundamental
  • Price
  • HHS $5.41
  • BRNS $1.11
  • Analyst Decision
  • HHS
  • BRNS Strong Buy
  • Analyst Count
  • HHS 0
  • BRNS 2
  • Target Price
  • HHS N/A
  • BRNS $4.00
  • AVG Volume (30 Days)
  • HHS 24.1K
  • BRNS 64.8K
  • Earning Date
  • HHS 11-14-2024
  • BRNS 11-06-2024
  • Dividend Yield
  • HHS N/A
  • BRNS N/A
  • EPS Growth
  • HHS N/A
  • BRNS N/A
  • EPS
  • HHS N/A
  • BRNS N/A
  • Revenue
  • HHS $187,604,000.00
  • BRNS $14,969,000.00
  • Revenue This Year
  • HHS N/A
  • BRNS $1,805.74
  • Revenue Next Year
  • HHS $4.05
  • BRNS N/A
  • P/E Ratio
  • HHS N/A
  • BRNS N/A
  • Revenue Growth
  • HHS N/A
  • BRNS 106.21
  • 52 Week Low
  • HHS $5.31
  • BRNS $0.80
  • 52 Week High
  • HHS $8.87
  • BRNS $4.16
  • Technical
  • Relative Strength Index (RSI)
  • HHS 33.68
  • BRNS 54.91
  • Support Level
  • HHS $5.73
  • BRNS $0.98
  • Resistance Level
  • HHS $5.98
  • BRNS $1.25
  • Average True Range (ATR)
  • HHS 0.27
  • BRNS 0.14
  • MACD
  • HHS 0.01
  • BRNS 0.03
  • Stochastic Oscillator
  • HHS 11.24
  • BRNS 68.82

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Share on Social Networks: